Eric Burak

2020

In 2020, Eric Burak earned a total compensation of $1.8M as Chief Scientific Officer at Fusion Pharmaceuticals, a 277% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$186,902
Option Awards$1,221,626
Salary$388,277
Other$25,604
Total$1,822,409

Burak received $1.2M in option awards, accounting for 67% of the total pay in 2020.

Burak also received $186.9K in non-equity incentive plan, $388.3K in salary and $25.6K in other compensation.

Rankings

In 2020, Eric Burak's compensation ranked 5,950th out of 13,090 executives tracked by ExecPay. In other words, Burak earned more than 54.5% of executives.

ClassificationRankingPercentile
All
5,950
out of 13,090
55th
Division
Manufacturing
2,448
out of 5,621
56th
Major group
Chemicals And Allied Products
978
out of 2,254
57th
Industry group
Drugs
846
out of 1,954
57th
Industry
Biological Products, Except Diagnostic Substances
207
out of 411
50th
Source: SEC filing on April 27, 2021.

Burak's colleagues

We found three more compensation records of executives who worked with Eric Burak at Fusion Pharmaceuticals in 2020.

2020

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2020

James O'Leary

Fusion Pharmaceuticals

Chief Medical Officer

2020

John Crowley

Fusion Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like